Frequency of pancreatitis after endoscopic retrograde cholangiopancreatography with iopromid or iotrolan: A randomized trial

European Radiology

Volumn 10, Issue 4, 2000, Pages 677-680

  Goebel, C ^a   Hardt, P ^a   Doppl, W ^a   Temme, H ^a   Hackstein, N ^a   Klor H U ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Contrast media toxicity; Endoscopic retrograde cholangiopancreatography; Iopromide; Iotrolan; Pancreatitis

Indexed keywords

AMYLASE; C REACTIVE PROTEIN; CALCIUM; IOPROMIDE; IOTROLAN; MACROGLOBULIN; TRIACYLGLYCEROL LIPASE; TRYPSIN INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INCIDENCE; MALE; PANCREATITIS; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0034044998     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050983     Document Type: Article

References (22)

1. Bilbao MK, Dotter CT, Lee TG, Kanton RM (1976) Complications of endoscopic retrograde cholangiopancreaticographie (ERCP). Gastroenterol 70: 314-320
2. Sherman S, Lehman GA (1990) Complications of ERCP and endoscopic sphincterotomy: management and prevention. In: Barkin JS, O'Phelan CA (eds) Advanced therapeutic endoscopy. Raven Press, New York, pp 201-210
3. Sternlieb JM, Aronchick CA, Retig JN, Dabezies M, Saunders F, Goosenberg E, Infantolino A, Ionna S, Maislin G, Wright SH, Lipshutz WH (1992) A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol 87: 1561-1566
4. Kivisaart L (1979) Contrast absorption and pancreatic inflammation following experimental ERCP. Invest Radiol 14: 493-497
5. Cohen N, Lipshutz W, Wright S, Aronchick C (1989) Pancreatic duct occlusion: a possible etiologic factor in pancreatitis post-ERCP and sphincter of Oddi manometry. Gastrointest Endosc 35: 190A
6. Podolsky I, Haber GB, Kortan P, Gray R (1988) Risk factors of pancreatitis following ERCP: a prospective study. Am J Gastroenterol 83: 1072A
7. Bub H, Burner W, Riemann JF, Stolte M (1985) Morphology of the pancreatic ductal epithelium after traumatisation of papilla of Vater of endoscopic retrograde pancreatography with contrast media in cats. Scand J Gastroenterol 20: 83-86
8. Almen T (1989) Relations between chemical structure, animal toxicity and clinical adverse effects of contrast media. In: Enge I, Edgren J (eds) Patients safety and adverse events in contrast medium examinations. Excerpta Medica Int Congr Series 816: 25-45
9. Jensen AR, Malchow-Moller A, Matzen P, Larsen JE, Andersen JR, Magid E (1985) A randomized trial of iohexol versus amidotrizoate in endoscopic retrograde pancreatography. Scand J Gastroenterol 20: 83-86
10. O'Connor HJ, Ellis WR, Manning AP, Lintott DJ, McMahon MJ, Axon ATR (1988) Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomized comparison with diatrizoate. Endoscopy 20: 244-247
11. Johnson GK, Geenen JE, Bedford RA, Johanson J, Cass O, Sherman S, Hogan WJ, Ryan M, Silverman W, Edmundowicz S et al. (1995) A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc 42: 312-316
12. Sherman S, Hawes RH, Rathgaber SW, Uzer MF, Smith MT, Khusro QE, Silverman WB, Earle DT, Lehman GA (1994) Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 40: 422-427
13. Doppl WE, Weber HP, Temme H, Klör HU, Federlin K (1996) Evaluation of ERCP- and endoscopic sphincterotomy-induced pancreatic damage: a prospective study on the time course and the significance of serum levels of pancreatic secretory enzymes. Eur J Med Res 1: 303-311
14. Levitt MD, Eckfeldt JH (1993) Diagnosis of acute pancreatitis. In: Go VLW et al. (eds) The pancreas: biology, pathobiology and disease, 2nd edn. Raven press, New York, pp 613-635
15. Sherman S, Lehman GA (1991) ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 6: 350-367
16. La Ferla G, Gordon S, Archibald M, Murray WR (1986) Hyperamylasemia following endoscopic retrograde cholangiopancreatography. Pancreas 1: 60-63
17. Osnes M, Skjennald A, Larsen S (1977) A comparison of a new non-ionic (metrizamide) and a dissociable (metrizoate) contrast medium in endoscope retrograde pancreatography (ERP). Scand J Gastroenterol 12: 821-825
18. Barkin JS, Casal GL, Reiner DK, Goldberg RI, Phillips RS, Kaplan S (1991) A comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroenterol 86: 1437-1441
19. Banerjee AK, Grainger SL, Thompson RPH (1990) Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography. Br J Clin Pract 44: 445-447
20. Cunliffe WJ, Cobden I, Lavelle MI, Lendrum R, Tait NP, Venables CW (1987) A randomized, prospective study comparing two contrast media in ERCP. Endoscopy 19: 201
21. Hamilton I, Lintott DJ, Rothwell J, Axon ATR (1982) Metrizamide as contrast medium in endoscopic retrograde cholangiopancreatography. Clin Radiol 33: 293-295
22. Hannigan BF, Keeling PWN, Slawin B, Thompson RPH (1985) Hyperamylasemia after ERCP with ionic and non-ionic contrast media. Gastrointest Endosc 31: 109